Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schottenfeld

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
The American Journal on Addictions|April 9, 2008
Research- and community-based clinicians' attitudes on treatment manualsDeclan T Barry, Melissa D Fulgieri, Meaghan E Lavery, et al.
The American Journal on Addictions|February 6, 2010
The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependenceLynn E Sullivan, Brent A Moore, Patrick G O'Connor, et al.
Journal of General Internal Medicine|March 21, 2007
Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patientsBrent A Moore, David A Fiellin, Declan T Barry, et al.
Journal of Clinical and Experimental Neuropsychology|September 18, 2013
Impulsivity, cognitive function, and their relationship in heroin-dependent individualsH Zeng, Tatia M C Lee, J H Waters, et al.
Journal of Addiction Medicine|November 6, 2013
HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatmentE Jennifer Edelman, Brent A Moore, Sarah Caffrey, et al.
Drug and Alcohol Dependence|March 5, 2021
Psychiatric comorbidity and order of condition onset among patients seeking treatment for chronic pain and opioid use disorderDeclan T Barry, Mark Beitel, Christopher J Cutter, et al.
Journal of Substance Abuse Treatment|October 16, 2007
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviorsLynn E Sullivan, Brent A Moore, Marek C Chawarski, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxoneLynn E Sullivan, Michael Botsko, Chinazo O Cunningham, et al.
Psychotherapy (Chicago, Ill.)|March 23, 2018
Psychotherapy with American Indians: An exploration of therapist-rated techniques in three urban clinicsMark Beitel, Laurelle L Myhra, Joseph P Gone, et al.
Journal of Substance Abuse Treatment|October 26, 2016
Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine TreatmentBrent A Moore, David A Fiellin, Christopher J Cutter, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
The American Journal on Addictions|April 9, 2008
Research- and community-based clinicians' attitudes on treatment manualsDeclan T Barry, Melissa D Fulgieri, Meaghan E Lavery, et al.
The American Journal on Addictions|February 6, 2010
The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependenceLynn E Sullivan, Brent A Moore, Patrick G O'Connor, et al.
Journal of General Internal Medicine|March 21, 2007
Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patientsBrent A Moore, David A Fiellin, Declan T Barry, et al.
Journal of Clinical and Experimental Neuropsychology|September 18, 2013
Impulsivity, cognitive function, and their relationship in heroin-dependent individualsH Zeng, Tatia M C Lee, J H Waters, et al.
Journal of Addiction Medicine|November 6, 2013
HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatmentE Jennifer Edelman, Brent A Moore, Sarah Caffrey, et al.
Drug and Alcohol Dependence|March 5, 2021
Psychiatric comorbidity and order of condition onset among patients seeking treatment for chronic pain and opioid use disorderDeclan T Barry, Mark Beitel, Christopher J Cutter, et al.
Journal of Substance Abuse Treatment|October 16, 2007
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviorsLynn E Sullivan, Brent A Moore, Marek C Chawarski, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxoneLynn E Sullivan, Michael Botsko, Chinazo O Cunningham, et al.
Psychotherapy (Chicago, Ill.)|March 23, 2018
Psychotherapy with American Indians: An exploration of therapist-rated techniques in three urban clinicsMark Beitel, Laurelle L Myhra, Joseph P Gone, et al.
Journal of Substance Abuse Treatment|October 26, 2016
Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine TreatmentBrent A Moore, David A Fiellin, Christopher J Cutter, et al.
Pageof 12